Research Interests
Pharmacology and Pharmaceutical SciencesGillian Caughey
School of Medicine
College of Health
Dr Gillian Caughey - Senior Research Fellow - Adelaide Medical School.Adjunct Senior Research Fellow School of Pharmacy and Medical Sciences, The University of South Australia. My research aims to improve medication-related care and health outcomes for older people with multimorbidity. Specifically, it focuses on the utilisation, safety and efficacy of medicines, using a range of research methods and data, including electronic health records and administrative claims health data. This research facilitates the development of the evidence base for the therapeutic management of patients with multimorbidity and to understand the complex interactions between common combinations of treatments for chronic conditions and develop holistic models of care.
| Date | Position | Institution name |
|---|---|---|
| 2016 - ongoing | Senior Research Fellow | University of Adelaide, Adelaide |
| 2016 - ongoing | Director of Research | Royal Adelaide Hospital, Adelaide |
| 2006 - ongoing | Adjunct Senior Research Fellow | University of South Australia, Adelaide |
| Date | Institution name | Country | Title |
|---|---|---|---|
| School of Medicine, University of Adelaide, Adelaide | Australia | PhD |
| Year | Citation |
|---|---|
| 2025 | Caughey, G. E., Air, T., Rahja, M., & Inacio, M. C. (2025). The oral health care needs of people living in residential aged care, Australia, 2016-20: a retrospective cross-sectional study. Medical Journal of Australia, 222(6), 318-320. |
| 2025 | Hughes, G. A., Inacio, M. C., Rowett, D., Caughey, G. E., Air, T., Lang, C. E., . . . Sluggett, J. K. (2025). Risk of adverse outcomes associated with mirtazapine compared to sertraline use among older people living in long-term care facilities. Age and Ageing, 54(4), 12 pages. Scopus4 WoS3 Europe PMC3 |
| 2025 | Inacio, M. C., Ryan, O., Gray, L. C., & Caughey, G. E. (2025). Monitoring cross-setting care and outcomes among older people in aged care: A national framework is needed. Australian Health Review, 49(2), AH24294-1-AH24294-5. Scopus1 WoS1 Europe PMC1 |
| 2025 | Harrison, S. L., Harries, D., Fu, H. M., Caughey, G. E., Comans, T., Corlis, M., & Inacio, M. C. (2025). Long-Term Care Staffing: Associations with Facility Characteristics, Residents’ Experience, and Quality Measures. Journal of the American Medical Directors Association, 26(7), 105686-1-105686-8. Scopus1 |
| 2025 | Wondimkun, Y. A., Caughey, G. E., Inacio, M. C., Air, T., Lang, C., Hogan, M., & Sluggett, J. K. (2025). Factors Associated With Hospitalization for Hypoglycemia and Hyperglycemia Among Older People in Long-Term Care Facilities. Journal of The American Geriatrics Society, 73(9), 2859-2867. Scopus6 WoS6 Europe PMC6 |
| 2025 | Eshetie, T. C., Caughey, G. E., Lang, C., Ryan, O., Visvanathan, R., Whitehead, C., . . . Inacio, M. C. (2025). The prevalence of and variation in indicators of the quality and safety of long term aged care in Australia, 2019: a cross-sectional population-based study.. Medical Journal of Australia, 223(4), 189-196. Scopus1 WoS1 |
| 2025 | Caughey, G. E., Rahja, M., Fernando, R., & Inacio, M. C. (2025). Quality Indicators to Monitor Care in Long-Term Care Facilities: A Scoping Review. Journal of the American Medical Directors Association, 26(10), 11 pages. WoS1 |
| 2025 | Eley, S., Wyman, C., Turner, C., Caughey, G. E., Williams, K., Keane, M. C., . . . Inacio, M. C. (2025). Enhancing registry impact: Translating registry outputs into Consumer-Friendly Information (CoFI project) through consumer co-design. Health Information Management Journal, 7 pages. |
| 2025 | Inacio, M. C., Harrison, S., Schwabe, J., Crotty, M., & Caughey, G. E. (2025). Models of care across settings supporting ageing in place: a narrative review. Medical Journal of Australia, 223(4), 218-225. Scopus1 WoS1 |
| 2025 | Gutteridge, D. S., Calder, A. H., Stasinopoulos, J., Javanparast, S., Caughey, G. E., Hillen, J. B., . . . Sluggett, J. K. (2025). Quality indicators for safe and effective use of medications in long-term care settings: A systematic review. British Journal of Clinical Pharmacology, 91(11), 3054-3069. Europe PMC1 |
| 2025 | Eshetie, T. C., Caughey, G. E., Lang, C., Whitehead, C., Crotty, M., Corlis, M., . . . Inacio, M. C. (2025). The risk of delirium or dementia-related hospitalization among individuals living with dementia after long-term care entry: A population-based risk prediction model. Alzheimer S and Dementia, 21(8), e70487. |
| 2025 | Javanparast, S., Gutteridge, D. S., Hibbert, P. D., Manias, E., Stafford, A. C., Peterson, G. M., . . . Sluggett, J. K. (2025). The Aged Care Onsite Pharmacist (ACOP) program in Australia: a qualitative study to examine key considerations for successful implementation in residential aged care homes. International Journal of Clinical Pharmacy, 13 pages. |
| 2025 | Caughey, G. E., Rahja, M., Harrison, S., Fernando, R., & Inacio, M. C. (2025). Quality Indicators to Monitor Home Care Services for the Older Population: A Scoping Review. Journal of the American Medical Directors Association, 26(11), 105876-1-105876-10. Scopus1 |
| 2025 | Schwabe, J., Pulling, B. W., Caughey, G. E., Crotty, M., Williams, H., Kellie, A., . . . Inacio, M. C. (2025). Variation in healthcare services utilization and continuity of care in long-term care facilities: a cross-sectional study. BMC Health Services Research, 25(1), 1216-1-1216-18. |
| 2025 | Wondimkun, Y. A., Caughey, G. E., Inacio, M. C., Air, T., Lang, C., Hogan, M., & Sluggett, J. K. (2025). Reply to Comments on Factors Associated With Hospitalization for Hypoglycemia and Hyperglycemia Among Older People in Long-Term Care Facilities. Journal of The American Geriatrics Society, 1-2. |
| 2025 | Wondimkun, Y. A., Caughey, G. E., Inacio, M. C., Air, T., & Sluggett, J. K. (2025). Cardiovascular Safety of Dipeptidyl Peptidase 4 Inhibitors Compared With Insulin or Sulfonylureas Added to Metformin Among Older People With Diabetes Living in Long-Term Care Facilities. Journal of the American Medical Directors Association, 26(12), 8 pages. |
| 2025 | Fernando, R. L., Inacio, M. C., Sluggett, J. K., Ward, S. A., Beattie, E., Khadka, J., & Caughey, G. E. (2025). Quality and Safety Indicators for Care Transitions by Older Adults: A Scoping Review. Journal of the American Medical Directors Association, 26(3), 105424-1-105424-15. Scopus1 WoS1 Europe PMC1 |
| 2025 | Hughes, G. A., Inacio, M. C., Rowett, D., Caughey, G. E., Air, T., Lang, C., . . . Sluggett, J. K. (2025). Prolonged Use of Antidepressants Among Older People Residing in Long-Term Care Facilities. Journal of the American Medical Directors Association (JAMDA): long-term care: management, applied research and clinical issues, 26(4), 105482-1-105482-7. Scopus1 WoS1 Europe PMC1 |
| 2025 | Suen, J., Fernando, R. L., Inacio, M. C., Crotty, M., Lin, X., & Caughey, G. E. (2025). Identification of Quality Indicators Used to Monitor, Evaluate and Improve Rural and Remote Care for Older People: A Scoping Review. Australian Journal of Rural Health, 33(6), 14 pages. |
| 2024 | Harrison, S. L., Lang, C., Eshetie, T. C., Crotty, M., Whitehead, C., Evans, K., . . . Inacio, M. C. (2024). Corrigendum to: Hospitalisations and emergency department presentations by older individuals accessing long-term aged care in Australia. Australian Health Review A Publication of the Australian Hospital Association, 49(1), AH24019_CO. |
| 2024 | Pearce, E., Rogers, G., Carpenter, L., Inacio, M. C., Caughey, G. E., Shoubridge, A., . . . Sluggett, J. K. (2024). Validity of Pharmaceutical Claims Data for Determining Medication Exposure in Long-Term Care Facilities. Pharmacoepidemiology and Drug Safety, 33(12), e70065-1-e70065-8. Scopus1 WoS1 Europe PMC1 |
| 2024 | Schwabe, J., Caughey, G. E., Jorissen, R., Comans, T., Gray, L., Westbrook, J., . . . Inacio, M. C. (2024). Setting standards in residential aged care: identifying achievable benchmarks of care for long-term aged care services. International Journal for Quality in Health Care, 36(4), 10 pages. Scopus1 WoS1 Europe PMC1 |
| 2024 | Khadka, J., Ratcliffe, J., Caughey, G., Air, T., Wesselingh, S., Corlis, M., . . . Inacio, M. (2024). Corrigendum to: Variation in direct healthcare costs to the health system by residents living in long-term care facilities: a Registry of Senior Australians study. Australian Health Review A Publication of the Australian Hospital Association, 48(5), 616. Scopus1 WoS1 Europe PMC1 |
| 2024 | Tiruye, T., O'Callaghan, M., FitzGerald, L. M., Moretti, K., Jay, A., Higgs, B., . . . Beckmann, K. (2024). Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection. Clinical Genitourinary Cancer, 22(2), 599-609.e2. Scopus8 WoS8 Europe PMC6 |
| 2024 | Davies, L. W., Air, T., Jorissen, R. N., Schwabe, J., Mittinty, M. M., Caughey, G., . . . Inacio, M. C. (2024). Historical Trends of Home Care Package Use for Older People in Australia, 2008–2021. Journal of the American Medical Directors Association, 25(6), 5 pages. Scopus1 WoS1 Europe PMC1 |
| 2024 | Thapaliya, K., Caughey, G. E., Crotty, M., Williams, H., Wesselingh, S. L., Roder, D., . . . Inacio, M. C. (2024). Primary, allied health, selected specialists, and mental health service utilisation by home care recipients in Australia before and after accessing the care, 2017–2019. Aging Clinical and Experimental Research, 36(1), 12 pages. Scopus3 WoS3 Europe PMC1 |
| 2024 | Harrison, S. L., Lang, C., Eshetie, T. C., Crotty, M., Whitehead, C., Evans, K., . . . Inacio, M. C. (2024). Hospitalisations and emergency department presentations by older individuals accessing long-term aged care in Australia. Australian Health Review, 48(2), 182-190. Scopus5 WoS5 Europe PMC3 |
| 2024 | Wondimkun, Y. A., Caughey, G. E., Inacio, M. C., Hughes, G. A., Air, T., Jorissen, R. N., . . . Sluggett, J. K. (2024). National trends in utilisation of glucose lowering medicines by older people with diabetes in long-term care facilities. Diabetes Research and Clinical Practice, 212, 111701-1-111701-7. Scopus5 WoS5 Europe PMC5 |
| 2024 | Tiruye, T., Roder, D., FitzGerald, L. M., O'Callaghan, M., Moretti, K., Caughey, G. E., & Beckmann, K. (2024). Impact of comorbidities on prostate cancer-specific mortality: A population-based cohort study. Prostate, 84(12), 1138-1145. Scopus10 WoS9 Europe PMC9 |
| 2024 | Lathlean, T. J. H., Inacio, M. C., Westbrook, J., Gray, L., Braithwaite, J., Hibbert, P., . . . Caughey, G. E. (2024). Quality indicators to monitor the quality and safety of care for older people: A scoping review protocol. Jbi Evidence Synthesis, 22(9), 1857-1865. Scopus2 WoS2 Europe PMC2 |
| 2024 | Inglis, J. M., Caughey, G., Thynne, T., Brotherton, K., Liew, D., Mangoni, A. A., & Shakib, S. (2024). Association of Drug–Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis. Drugs Real World Outcomes, 11(3), 345-360. Scopus3 WoS3 Europe PMC2 |
| 2024 | Humphrey, G. B., Inacio, M. C., Lang, C., Churches, O. F., Sluggett, J. K., Williams, H., . . . Caughey, G. E. (2024). Estimating potential palliative care needs for residential aged care: A population-based retrospective cohort study. Australasian Journal on Ageing, 43(4), 1-10. Scopus6 WoS6 Europe PMC7 |
| 2024 | Sluggett, J. K., Inacio, M. C., & Caughey, G. E. (2024). Medication management in long-term care: using evidence generated from real-world data to effect policy change in the Australian setting. American Journal of Epidemiology, 193(12), 1645-1649. Scopus3 WoS3 Europe PMC5 |
| 2024 | Tiruye, T., Hiwase, M., Charlick, M., O'Callaghan, M., Khalid, A., Li, M., . . . Beckmann, K. (2024). Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer. Psychooncology, 33(7), e6369-1-e6369-11. Scopus1 WoS2 |
| 2024 | Pearson, O., Air, T., Humphrey, G., Bradley, C., Tunny, N., Brown, A., . . . Caughey, G. E. (2024). Aged care service use by Aboriginal and Torres Strait Islander people after aged care eligibility assessments, 2017-2019: a population-based retrospective cohort study. Medical Journal of Australia, 221(1), 31-38. |
| 2024 | Schwabe, J., Caughey, G. E., Wesselingh, S. L., Whitehead, C., Visvanathan, R., Evans, K., & Inacio, M. C. (2024). The impact of ageing-in-place reforms on the provision of home care packages for older Australians, 2008–21: a repeated cross-sectional study. Medical Journal of Australia, 221(5), 264-269. Scopus2 WoS2 Europe PMC2 |
| 2024 | Inglis, J. M., Caughey, G., Thynne, T., Brotherton, K., Liew, D., Mangoni, A. A., & Shakib, S. (2024). Inappropriate prescribing and association with readmission or mortality in hospitalised older adults with frailty: a systematic review and meta-analysis.. BMC Geriatrics, 24(1), 18 pages. Scopus2 WoS1 Europe PMC1 |
| 2024 | Sluggett, J. K., Caughey, G. E., Air, T., Lang, C., Moldovan, M., Martin, G., . . . Inacio, M. C. (2024). Health outcomes following provision of Home Medicines Reviews for older people receiving aged care services at home. Research in Social and Administrative Pharmacy, 20(11), 1064-1069. Scopus1 WoS1 Europe PMC1 |
| 2024 | Wondimkun, Y. A., Caughey, G. E., Inacio, M. C., Air, T., Lang, C., & Sluggett, J. K. (2024). Glucose-lowering medicines use before and after entry into long-term care facilities. Diabetes, Obesity and Metabolism, 26(11), 4966-4975. Scopus2 WoS2 |
| 2024 | Harrison, S. L., Harries, D., Lin, Y., Caughey, G. E., Miller, C., & Inacio, M. C. (2024). Star Ratings in Long-Term Care Facilities in Australia: Facility Characteristics Associated With High Ratings and Changes in Ratings Over Time. J Am Med Dir Assoc, 25(11), 105272-1-105272-8. Scopus6 WoS5 Europe PMC3 |
| 2024 | Khadka, J., Ratcliffe, J., Caughey, G., Air, T., Wesselingh, S., Corlis, M., . . . Inacio, M. (2024). Variation in direct healthcare costs to the health system by residents living in long-term care facilities: a Registry of Senior Australians study. Australian Health Review, 48(5), 511-518. Scopus2 WoS1 Europe PMC2 |
| 2024 | Caughey, G. E., Rahja, M., Collier, L., Air, T., Thapaliya, K., Crotty, M., . . . ROSA Primary Care Research Collaborators. (2024). Primary health care service utilisation before and after entry into long-term care in Australia. Archives of Gerontology and Geriatrics, 117, 105210-1-105210-9. Scopus2 WoS2 Europe PMC2 |
| 2024 | Davies, L. W., Air, T., Jorissen, R. N., Mittinty, M. N., Caughey, G., Wesselingh, S., & Inacio, M. C. (2024). Historical Trends and Future Projections of Demand for Permanent Residential Aged Care for Older People in Australia, 2008–2052. Journal of the American Medical Directors Association, 25(2), 252-258.e8. Scopus5 WoS5 Europe PMC5 |
| 2024 | Inacio, M. C., Davies, L., Jorissen, R., Air, T., Eshetie, T., Mittinty, M., . . . Wesselingh, S. (2024). Excess mortality in residents of aged care facilities during COVID-19 in Australia, 2019-22. International Journal of Epidemiology, 53(1), dyad168-1-dyad168-8. Scopus3 WoS3 |
| 2024 | Eshetie, T. C., Caughey, G. E., Whitehead, C., Crotty, M., Corlis, M., Visvanathan, R., . . . Inacio, M. C. (2024). The risk of fractures after entering long-term care facilities. Bone, 180, 116995. Scopus3 WoS3 Europe PMC2 |
| 2024 | Sluggett, J. K., Caughey, G. E., Air, T., Cations, M., Lang, C., Ward, S. A., . . . Inacio, M. C. (2024). National surveillance using a clinical quality indicator for prolonged antipsychotic use among older Australians living with dementia who access aged care services. International Journal of Geriatric Psychiatry, 39(5), e6089-1-e6089-11. Scopus4 WoS4 Europe PMC3 |
| 2024 | Westbrook, J. I., Seaman, K., Wabe, N., Raban, M. Z., Urwin, R., Badgery-Parker, T., . . . Cumming, A. (2024). Designing an Informatics Infrastructure for a National Aged Care Medication Roundtable. Studies in Health Technology and Informatics, 310, 404-408. Scopus3 Europe PMC3 |
| 2023 | Wondimkun, Y. A., Caughey, G. E., Inacio, M. C., Lang, C., Hogan, M., & Sluggett, J. K. (2023). Diabetes ascertainment among older Australians residing in long-term care facilities. Journal of the American Geriatrics Society, 72(3), 946-948. Scopus4 WoS5 Europe PMC3 |
| 2023 | Sluggett, J. K., Air, T., Cations, M., Caughey, G. E., Lang, C. E., Ward, S. A., . . . Inacio, M. C. (2023). Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services. Journal of Alzheimer's Disease, 96(4), 1747-1758. Scopus2 WoS2 Europe PMC2 |
| 2023 | Thapaliya, K., Cornell, V., Lang, C., Caughey, G. E., Barker, A., Evans, K., . . . Inacio, M. C. (2023). Aged and Health Care Service Utilization by Older Australians Receiving Home Care Packages. Journal of the American Medical Directors Association, 24(3), 395-399.e2. Scopus6 WoS5 Europe PMC5 |
| 2023 | Eshetie, T. C., Moldovan, M., Caughey, G. E., Lang, C., Sluggett, J. K., Khadka, J., . . . Inacio, M. C. (2023). Development of a Multivariable Prediction Model for Risk of Hospitalization With Pressure Injury After Entering Residential Aged Care. Journal of the American Medical Directors Association (JAMDA): long-term care: management, applied research and clinical issues, 24(3), 299-306.e9. Scopus4 WoS4 Europe PMC3 |
| 2023 | Cations, M., Lang, C., Draper, B., Caughey, G. E., Evans, K., Wesselingh, S., . . . Inacio, M. C. (2023). Death by suicide among aged care recipients in Australia 2008-2017. International Psychogeriatrics, 35(12), 724-735. Scopus5 WoS6 Europe PMC3 |
| 2023 | Inacio, M. C., Eshetie, T. C., Caughey, G. E., Whitehead, C., Westbrook, J., Gray, L., . . . Wesselingh, S. (2023). Quality and safety in residential aged care: an evaluation of a national quality indicator programme. Internal Medicine Journal, 53(11), 2073-2078. Scopus3 WoS5 Europe PMC3 |
| 2023 | Chen, T. C., Wettermark, B., Steinke, D., Caughey, G. E., Tadrous, M., Wirtz, V. J., & Chen, L. C. (2023). Feasibility and validity of using healthcare databases to conduct cross-national comparative studies of opioid use, its determinants and consequences. Pharmacoepidemiology and Drug Safety, 32(9), 1021-1031. |
| 2023 | Caughey, G. E., Collier, L., Cations, M., Wesselingh, S., & Inacio, M. C. (2023). Evaluation of Uptake of COVID-19 Temporary Allied Health Services for Residential Aged Care in Australia. Journal of the American Medical Directors Association (JAMDA), 24(6), 917-925. |
| 2023 | Inacio, M. C., Collier, L., Air, T., Thapaliya, K., Crotty, M., Williams, H., . . . Caughey, G. E. (2023). Primary, allied health, geriatric, pain and palliative healthcare service utilisation by aged care residents, 2012-2017. Australasian journal on ageing, 42(3), 564-576. Scopus4 WoS4 Europe PMC4 |
| 2022 | Li, R. J., Caughey, G. E., & Shakib, S. (2022). Appropriateness of inpatient dosing of direct oral anticoagulants for atrial fibrillation.. J Thromb Thrombolysis, 53(2), 425-435. Scopus7 WoS6 Europe PMC5 |
| 2022 | Gillam, M. H., Pratt, N. L., Inacio, M. C. S., Shakib, S., Caughey, G. E., Sanders, P., . . . Roughead, E. E. (2022). Cardiac implantable electronic devices: reoperations and the competing risk of death. Heart Lung and Circulation, 31(4), 537-543. |
| 2022 | Caughey, G. E., Jorissen, R. N., Lang, C., Wesselingh, S. L., & Inacio, M. C. (2022). Hospitalisation for lower respiratory viral infections in older people in residential aged care facilities. Australasian Journal on Ageing, 41(1), e58-e66. Scopus5 WoS5 Europe PMC4 |
| 2022 | Jorissen, R. N., Crotty, M., Caughey, G. E., Harvey, G., & Inacio, M. C. (2022). Hospitalizations Before and After Entry Into Long-Term Care. Journal of the American Medical Directors Association, 23(8), 1429-1430. Scopus9 WoS8 Europe PMC6 |
| 2022 | Sluggett, J. K., Caughey, G. E., Air, T., Moldovan, M., Lang, C., Martin, G., . . . Inacio, M. C. (2022). Medicines use before and after comprehensive medicines review among residents of long-term care facilities: a retrospective cohort study. BMC Geriatrics, 22(1), 493-1-493-15. Scopus18 WoS17 Europe PMC15 |
| 2022 | Dyer, S. M., Suen, J., Williams, H., Inacio, M. C., Harvey, G., Roder, D., . . . Caughey, G. E. (2022). Impact of relational continuity of primary care in aged care: a systematic review. BMC Geriatrics, 22(1), 1-18. Scopus26 WoS24 Europe PMC20 |
| 2022 | Sluggett, J. K., Caughey, G. E., Air, T., Moldovan, M., Lang, C., Martin, G., . . . Inacio, M. C. (2022). Provision of a comprehensive medicines review is associated with lower mortality risk for residents of aged care facilities: a retrospective cohort study. Age and Ageing, 51(7), 1-11. Scopus15 WoS15 Europe PMC13 |
| 2022 | Cations, M., Collier, L. R., Caughey, G., Bartholomaeus, J., Lang, C., Crotty, M., . . . Inacio, M. C. (2022). Government-subsidised mental health services are underused in Australian residential aged care facilities. Australian Health Review, 46(4), 432-441. Scopus15 WoS15 Europe PMC10 |
| 2022 | Rahja, M., Air, T., Ahern, S., Ward, S. A., Caughey, G. E., Sluggett, J. K., . . . Inacio, M. C. (2022). Primary and Secondary Care Related Quality Indicators for Dementia Care Among Australian Aged Care Users: National Trends, Risk Factors, and Variation. Journal of Alzheimer's Disease, 88(4), 1511-1522. Scopus6 WoS6 Europe PMC5 |
| 2022 | Bartholomaeus, J. D., Collier, L. R., Lang, C., Cations, M., Kellie, A. R., Inacio, M. C., & Caughey, G. E. (2022). Trends in mental health service utilisation by Australia's older population. Australasian Journal on Ageing, 42(1), 1-6. Scopus5 WoS5 Europe PMC4 |
| 2022 | Caughey, G. E., Lang, C. E., Bray, S. C. E., Sluggett, J. K., Whitehead, C., Visvanathan, R., . . . Inacio, M. C. (2022). Quality and safety indicators for home care recipients in Australia: development and cross-sectional analyses. BMJ Open, 12(8), e063152-1-e063152- 11. WoS8 |
| 2022 | Caughey, G. E., Sluggett, J. K., Lang, C., Wesselingh, S. L., & Inacio, M. C. (2022). National Monitoring of Medication-Related Quality of Care in Residential Aged Care: Is Australia Making Progress?. Journal of the American Medical Directors Association, 23(12), 2034-2037. Scopus5 WoS5 Europe PMC4 |
| 2022 | Inacio, M. C., Caughey, G. E., Wesselingh, S., & ROSA Research Team & Steering Committee Members. (2022). Registry of Senior Australians (ROSA): integrating cross-sectoral information to evaluate quality and safety of care provided to older people. BMJ Open, 12(11), 1-11. Scopus32 WoS30 Europe PMC22 |
| 2022 | ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022 (2022). Pharmacoepidemiology and Drug Safety, 31(S2), 3-628. |
| 2021 | Davis, K. M., Eckert, M. C., Hutchinson, A., Harmon, J., Sharplin, G., Shakib, S., & Caughey, G. E. (2021). Effectiveness of nurse–led services for people with chronic disease in achieving an outcome of continuity of care at the primary-secondary healthcare interface: A quantitative systematic review. International Journal of Nursing Studies, 121, 103986. Scopus38 WoS32 Europe PMC30 |
| 2021 | Khadka, J., Ratcliffe, J., Caughey, G. E., Wesselingh, S. L., & Inacio, M. C. (2021). Prevalence of eye conditions, utilization of eye health care services, and ophthalmic medications after entering residential aged care in Australia. Translational Vision Science and Technology, 10(14), 3-1-3-14. Scopus5 WoS4 Europe PMC4 |
| 2021 | Inacio, M. C., Moldovan, M., Whitehead, C., Sluggett, J. K., Crotty, M., Corlis, M., . . . Caughey, G. E. (2021). The risk of fall-related hospitalisations at entry into permanent residential aged care. BMC Geriatrics, 21(1), 686-1-686-13. Scopus21 WoS21 Europe PMC14 |
| 2021 | Sluggett, J. K., Collier, L. R., Bartholomaeus, J. D., Inacio, M. C., Wesselingh, S. L., & Caughey, G. E. (2021). National trends and policy impacts on provision of Home Medicines Reviews and Residential Medication Management Reviews in older Australians, 2009–2019. International Journal of Environmental Research and Public Health, 18(18), 9898-1-9898-10. Scopus8 WoS7 Europe PMC6 |
| 2021 | Gill, T. K., Caughey, G. E., Wesselingh, S., & Inacio, M. C. (2021). Impact of musculoskeletal conditions among those in residential aged care in Australia.. Australasian journal on ageing, 41(1), 10 pages. Scopus1 WoS1 Europe PMC1 |
| 2021 | Inglis, J. M., Caughey, G. E., Smith, W., & Shakib, S. (2021). Documentation of Adverse Drug Reactions to Opioids in an Electronic Health Record.. Intern Med J, 51(9), 1490-1496. Scopus8 WoS8 Europe PMC8 |
| 2021 | Li, R. J., Caughey, G. E., & Shakib, S. (2021). Concomitant inpatient prescribing of strong opioids with sedatives: Associations with comorbid conditions.. Pharmacol Res Perspect, 9(1), 1-7. Scopus4 WoS4 Europe PMC4 |
| 2021 | Parajuli, D. R., Shakib, S., Eng-Frost, J., McKinnon, R. A., Caughey, G. E., & Whitehead, D. (2021). Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients.. BMC cardiovascular disorders, 21(1), 1-16. Scopus11 WoS10 Europe PMC9 |
| 2021 | Sluggett, J. K., Dinh, Y. H., Wesselingh, S. L., Inacio, M. C., & Caughey, G. E. (2021). National changes in outpatient systemic antibiotic use during the Coronavirus disease 2019 pandemic in Australia. Clinical Infectious Diseases, 73(11), 2150-2152. Scopus9 WoS6 Europe PMC10 |
| 2021 | Cations, M., Lang, C., Ward, S. A., Caughey, G. E., Crotty, M., Whitehead, C., . . . Inacio, M. C. (2021). Using data linkage for national surveillance of clinical quality indicators for dementia care among Australian aged care users. Scientific Reports, 11(1), 10674. Scopus9 WoS9 Europe PMC7 |
| 2021 | Bartholomaeus, J. D., Inacio, M. C., Williams, H., Wesselingh, S. L., & Caughey, G. E. (2021). Primary healthcare utilisation by older Australians during the COVID-19 pandemic.. Internal medicine journal, 51(5), 818-820. Scopus3 WoS3 Europe PMC3 |
| 2021 | Jorissen, R. N., Inacio, M. C., Cations, M., Lang, C., Caughey, G. E., & Crotty, M. (2021). Effect of Dementia on Outcomes After Surgically Treated Hip Fracture in Older Adults. Journal of Arthroplasty, 36(9), 3181-3186. Scopus16 WoS15 Europe PMC16 |
| 2021 | Inacio, M. C., Jorissen, R. N., Khadka, J., Whitehead, C., Maddison, J., Bourke, A., . . . Crotty, M. (2021). Predictors of short-term hospitalization and emergency department presentations in aged care. Journal of the American Geriatrics Society, 69(11), 3142-3156. Scopus18 WoS18 Europe PMC16 |
| 2021 | Kalisch Ellett, L. M., Kassie, G. M., Caughey, G. E., Pratt, N. L., Ramsay, E. N., & Roughead, E. E. (2021). Medication-related hospital admissions in aged care residents. Australasian journal on ageing, 40(4), e323-e331. Scopus10 WoS9 Europe PMC10 |
| 2020 | Foreman, C., Smith, W. B., Caughey, G. E., & Shakib, S. (2020). Categorization of adverse drug reactions in electronic health records.. Pharmacol Res Perspect, 8(2), 1-7. Scopus22 WoS23 Europe PMC18 |
| 2020 | Inacio, M. C., Lang, C., Caughey, G. E., Bray, S. C. E., Harrison, S. L., Whitehead, C., . . . Wesselingh, S. (2020). The Registry of Senior Australians outcome monitoring system: quality and safety indicators for residential aged care. International Journal for Quality in Health Care, 32(8), 502-510. Scopus45 WoS45 Europe PMC39 |
| 2020 | Amare, A. T., Caughey, G. E., Whitehead, C., Lang, C. E., Bray, S. C. E., Corlis, M., . . . Inacio, M. C. (2020). The prevalence, trends and determinants of mental health disorders in older Australians living in permanent residential aged care: implications for policy and quality of aged care services. Australian and New Zealand Journal of Psychiatry, 54(12), 1200-1211. Scopus43 WoS40 Europe PMC26 |
| 2020 | Masnoon, N., Kalisch Ellett, L., Shakib, S., & Caughey, G. E. (2020). Predictors of Mortality in the Older Population: The Role of Polypharmacy and Other Medication and Chronic Disease-Related Factors. Drugs and Aging, 37(10), 767-776. Scopus16 WoS15 Europe PMC13 |
| 2020 | Davis, K. M., Eckert, M. C., Hutchinson, A., Harmon, J., Sharplin, G., Shakib, S., & Caughey, G. E. (2020). Continuity of care for people with multimorbidity: The development of a model for a nurse-led care coordination service. Australian Journal of Advanced Nursing, 37(4), 7-19. Scopus7 WoS5 |
| 2020 | Caughey, G. E., Inacio, M. C., Bell, J. S., Vitry, A. I., & Shakib, S. (2020). Inclusion of older people reflective of real-world clinical practice in cardiovascular drug trials. Journal of the American Heart Association, 9(21), e016936-1-e016936-8. Scopus16 WoS16 Europe PMC12 |
| 2020 | Hillen, J. B., Vitry, A., & Caughey, G. E. (2020). Erratum: Medication-related quality of care in residential aged care: an Australian experience (International Journal for Quality in Health Care (2018) (1-9) DOI: 10.1093/intqhc/mzy164). International Journal for Quality in Health Care, 32(7), 488. WoS4 Europe PMC1 |
| 2020 | Molga, A., Wall, M., Chhetri, R., Wee, L. Y., Singhal, D., Edwards, S., . . . Hiwase, D. (2020). Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromes. Journal of Geriatric Oncology, 11(1), 114-120. Scopus38 WoS34 Europe PMC29 |
| 2020 | Masnoon, N., Shakib, S., Kalisch Ellett, L., & Caughey, G. E. (2020). Predictors of unplanned hospitalisation in the older population: The role of polypharmacy and other medication and chronic disease-related factors. Australasian Journal on Ageing, 39(3), 436-446. Scopus4 WoS4 Europe PMC3 |
| 2020 | Masnoon, N., Shakib, S., Kalisch Ellett, L., & Caughey, G. E. (2020). Rationalisation of polypharmacy in practice: a survey of physicians and pharmacists. Journal of Pharmacy Practice and Research, 50(3), 233-241. Scopus5 |
| 2020 | Sluggett, J. K., Harrison, S. L., Ritchie, L. A., Clough, A. J., Rigby, D., Caughey, G. E., & Tan, E. C. K. (2020). High-Risk Medication Use in Older Residents of Long-Term Care Facilities: Prevalence, Harms, and Strategies to Mitigate Risks and Enhance Use.. The Senior care pharmacist, 35(10), 419-433. Europe PMC14 |
| 2020 | Special Issue: Abstracts of the 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, September 16-17, 2020 (2020). Pharmacoepidemiology and Drug Safety, 29(S3), 3-649. Scopus2 Europe PMC3 |
| 2019 | Davis, K. M., Eckert, M. C., Shakib, S., Harmon, J., Hutchinson, A. D., Sharplin, G., & Caughey, G. E. (2019). Development and implementation of a nurse-led model of care coordination to provide health-sector continuity of care for people with multimorbidity: Protocol for a mixed methods study. Jmir Research Protocols, 8(12), 12 pages. Scopus9 WoS9 Europe PMC6 |
| 2019 | Bessen, T., Caughey, G. E., Shakib, S., Potter, J. A., Reid, J., Farshid, G., . . . Neuhaus, S. J. (2019). A population-based study of soft tissue sarcoma incidence and survival in Australia: An analysis of 26,970 cases.. Cancer epidemiology, 63, 101590. Scopus39 WoS39 Europe PMC34 |
| 2019 | Pratt, N. L., Ramsay, E., Kalisch Ellett, L. M., Duszynski, K., Shakib, S., Kerr, M., . . . Roughead, E. E. (2019). Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study. BMJ Open, 9(5), e026486. Scopus9 WoS9 Europe PMC7 |
| 2019 | Inglis, J. M., Caughey, G. E., & Shakib, S. (2019). Use of non-formulary high-cost medicines in an Australian public hospital. International Journal of Clinical Pharmacy, 41(4), 920-931. Scopus6 WoS6 Europe PMC5 |
| 2019 | Hillen, J. B., Soulsby, N., Alderman, C., & Caughey, G. E. (2019). Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review.. Therapeutic advances in drug safety, 10, 23 pages. WoS34 Europe PMC26 |
| 2019 | Caughey, G. E., Shakib, S., Inglis, J. M., Le, T. T., Yuson, C. L., & Smith, W. B. (2019). External validation of beta-lactam antibiotic allergy assessment tools: implications for clinical practice and workforce capacity. Journal of Allergy and Clinical Immunology in Practice, 7(6), 2094-2095. Scopus5 WoS5 Europe PMC3 |
| 2019 | Caughey, G. E., Shakib, S., Barratt, J. D., & Roughead, E. E. (2019). Use of medicines that may exacerbate heart failure in older adults: therapeutic complexity of multimorbidity. Drugs and Aging, 36(5), 471-479. Scopus10 WoS10 Europe PMC8 |
| 2019 | Shakib, S., Caughey, G. E., Fok, J. S., & Smith, W. B. (2019). Adverse drug reaction classification by health professionals: Appropriate discrimination between allergy and intolerance?. Clinical and Translational Allergy, 9(18), 8 pages. Scopus14 WoS14 Europe PMC9 |
| 2019 | Caughey, G. E., Gadzhanova, S., Shakib, S., & Roughead, E. E. (2019). Concomitant prescribing of opioids and benzodiazepines in Australia, 2012–2017. Medical Journal of Australia, 210(1), 39-40. Scopus9 WoS9 Europe PMC7 |
| 2019 | Al-Sarawi, F., Polasek, T. M., Caughey, G. E., & Shakib, S. (2019). Prescribing errors and adverse drug reaction documentation before and after implementation of e-prescribing using the Enterprise Patient Administration System. Journal of Pharmacy Practice and Research, 49(1), 27-32. Scopus15 |
| 2019 | Caughey, G. E., Hillen, J. B., Bacon, S., Bullock, N., Bullock, V., & Kalisch-Ellett, L. M. (2019). Implementation of medication-related potentially preventable hospitalisation indicators in a chronic disease management program for multimorbidity.. International Journal for Quality in Health Care, 31(2), 133-139. Scopus2 WoS2 Europe PMC2 |
| 2019 | Tadros, R., Caughey, G. E., Johns, S., & Shakib, S. (2019). Comprehension and recall from the informed consent process by phase I healthy volunteers before dose administration. Clinical Trials, 16(3), 283-289. Scopus6 WoS6 Europe PMC6 |
| 2018 | Hillen, J. B., Vitry, A., & Caughey, G. E. (2018). Medication-related quality of care in residential aged care: an Australian experience.. International journal for quality in health care : journal of the International Society for Quality in Health Care, 31(4), 298-306. Scopus11 WoS10 Europe PMC8 |
| 2018 | Inacio, M., Cashman, K., Pratt, N., Gillam, M., Caughey, G., Graves, S., & Roughead, E. (2018). Prevalence and changes in analgesic medication utilisation 1 year prior to total joint replacement in an older cohort of patients. Osteoarthritis and Cartilage, 26(3), 356-362. Scopus25 WoS24 Europe PMC18 |
| 2018 | Caughey, G. E., Gabb, G., Ronson, S., Ward, M., Hill, C., Beukelman, T. G., & Limaye, V. (2018). Association of Statin Exposure with Histologically-Confirmed Idiopathic Inflammatory Myositis in an Australian Population. JAMA Internal Medicine, 178(9), 1224-1229. Scopus21 WoS21 Europe PMC16 |
| 2018 | Khoo, T., Caughey, G., Hill, C., & Limaye, V. (2018). Proton pump inhibitors are not associated with inflammatory myopathies: A case control study. Muscle and Nerve, 58(6), 855-857. Scopus4 WoS3 Europe PMC2 |
| 2018 | Farinola, N., Caughey, G., Bell, J., Johns, S., Hauta-aho, M., & Shakib, S. (2018). Influence of stroke and bleeding risk on prescribing of oral anticoagulants in older inpatients; has the availability of direct oral anticoagulants changed prescribing?. Therapeutic Advances in Drug Safety, 9(2), 113-121. Scopus8 WoS6 Europe PMC4 |
| 2018 | Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. (2018). Tools for Assessment of the Appropriateness of Prescribing and Association with Patient-Related Outcomes: A Systematic Review. Drugs and Aging, 35(1), 43-60. Scopus51 WoS49 Europe PMC43 |
| 2018 | Caughey, G. E., Gabb, G. M., & Ronson, S. (2018). Association of Statin Exposure With Histologically Confirmed Idiopathic Inflammatory Myositis in an Australian Population (vol 178, pg 1224, 2018). JAMA INTERNAL MEDICINE, 178(12), 1732. |
| 2017 | Caughey, G., Tait, K., Vitry, A., & Shakib, S. (2017). Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity. Patient Preference and Adherence, 11, 131-140. Scopus23 WoS20 Europe PMC16 |
| 2017 | Caughey, G., Pratt, N., Barratt, J., Shakib, S., Kemp-Casey, A., & Roughead, E. (2017). Understanding 30-day re-admission after hospitalisation of older patients for diabetes: Identifying those at greatest risk. Medical Journal of Australia, 206(4), 170-175. Scopus24 WoS22 Europe PMC19 |
| 2017 | Ong, G., Page, A., Caughey, G., Johns, S., Reeve, E., & Shakib, S. (2017). Clinician agreement and influence of medication-related characteristics on assessment of polypharmacy. Pharmacology Research and Perspectives, 5(3), 1-6. Scopus10 WoS9 Europe PMC6 |
| 2017 | Inglis, J., Caughey, G., Smith, W., & Shakib, S. (2017). Documentation of penicillin adverse drug reactions in electronic health records: inconsistent use of allergy and intolerance labels. Internal Medicine Journal, 47(11), 1292-1297. Scopus74 WoS72 Europe PMC54 |
| 2017 | Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatrics, 17(1), 1-10. Scopus2266 WoS2131 Europe PMC1718 |
| 2017 | Caughey, G. E., Barratt, J. D., Shakib, S., Kemp-Casey, A., & Roughead, E. E. (2017). Medication use and potentially high-risk prescribing in older patients hospitalized for diabetes: a missed opportunity to improve care?. Diabetic Medicine, 34(3), 432-439. Scopus17 WoS15 Europe PMC12 |
| 2017 | Caughey, G., Kalisch Ellett, L., Barratt, J., & Shakib, S. (2017). Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events. Therapeutic Advances in Drug Safety, 8(5), 157-164. Scopus8 WoS7 Europe PMC5 |
| 2017 | Demasi, M., Cleland, L. G., Cook-Johnson, R. J., Caughey, G. E., & James, M. J. (2017). Erratum: Effects of hypoxia on monocyte inflammatory mediator production: Dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis (Journal of Biological Chemistry (2003) 278 (38607–38616) DOI: 10.1074/jbc.M305944200). Journal of Biological Chemistry, 292(38), 15993. Scopus3 WoS3 Europe PMC2 |
| 2017 | Hillen, J., Vitry, A., & Caughey, G. (2017). Disease burden, comorbidity and geriatric syndromes in the Australian aged care population. Australasian Journal on Ageing, 36(2), 14-19. Scopus38 WoS37 Europe PMC30 |
| 2017 | Hillen, J., Vitry, A., & Caughey, G. (2017). Evaluating medication-related quality of care in Australian aged care: A role for collaborative health services. Journal of Pharmacy Practice and Research, 47(1), 63-66. Scopus3 |
| 2016 | Chen, E. Y. H., Diug, B., Bell, J. S., mc Namara, K. P., Dooley, M. J., Kirkpatrick, C. M., . . . Ilomäki, J. (2016). Spontaneously reported haemorrhagic adverse events associated with rivaroxaban and dabigatran in Australia. Therapeutic Advances in Drug Safety, 7(1), 4-10. Scopus9 WoS8 Europe PMC7 |
| 2016 | Parkinson, L., Moorin, R., Peeters, G., Byles, J., Blyth, F., Caughey, G., . . . Pond, D. (2016). Incident osteoarthritis associated with increased allied health services use in ‘baby boomer’ Australian women. Australian and New Zealand Journal of Public Health, 40(4), 356-361. Scopus3 WoS3 Europe PMC1 |
| 2016 | Hillen, J., Vitry, A., & Caughey, G. (2016). Trends in general practitioner services to residents in aged care. Australian Journal of Primary Health, 22(6), 517-522. Scopus11 WoS11 Europe PMC8 |
| 2016 | Pratt, N., Ramsay, E., Caughey, G., Shakib, S., & Roughead, E. (2016). Uptake of novel oral anticoagulants in Australia. Medical Journal of Australia, 204(3), 104-105. Scopus30 WoS26 Europe PMC21 |
| 2016 | Shakib, S., Dundon, B., Maddison, J., Thomas, J., Stanners, M., Caughey, G., & Clark, R. (2016). Effect of a multidisciplinary outpatient model of care on health outcomes in older patients with multimorbidity: a retrospective case control study. PLoS ONE, 11(8), e0161382-1-e0161382-11. Scopus24 WoS23 Europe PMC20 |
| 2016 | van Gaans, D., Ahmed, S., D’Onise, K., Moyon, J., Caughey, G., & McDermott, R. (2016). Modelling medications for public health research. Online Journal of Public Health Informatics, 8(2), 1-9. |
| 2016 | Caughey, G., Vitry, A., Ramsay, E., Gilbert, A., Shakib, S., Ryan, P., . . . Roughead, E. (2016). Effect of a general practitioner management plan on health outcomes and hospitalisations in older patients with diabetes. Internal Medicine Journal, 46(12), 1430-1436. Scopus13 WoS15 Europe PMC11 |
| 2015 | Hillen, J., Vitry, A., & Caughey, G. (2015). Evaluating medication-related quality of care in residential aged care: a systematic review. SpringerPlus, 4(1), 17 pages. Scopus20 WoS16 Europe PMC16 |
| 2015 | Nguyen, T., Caughey, G., Pratt, N., Shakib, S., Kemp, A., & Roughead, E. (2015). Hospitalization for drug-induced hepatotoxicity: linking Y-codes with pharmaceutical claims data to identify implicated medicines. Journal of Clinical Pharmacy and Therapeutics, 40(2), 213-219. Scopus2 WoS2 Europe PMC2 |
| 2015 | Parkinson, L., Magin, P., Thomson, A., Byles, J., Caughey, G., Etherton-Beer, C., . . . Pond, C. (2015). Anticholinergic burden in older women: not seeing the wood for the trees?. Medical Journal of Australia, 202(2), 91-95. Scopus22 WoS20 Europe PMC16 |
| 2015 | Mcdonald, C., Kalisch Ellett, L., Barratt, J., & Caughey, G. (2015). An international comparison of spontaneous adverse event reports and potentially inappropriate medicine use associated with dabigatran. Pharmacoepidemiology and Drug Safety, 24(4), 399-405. Scopus23 WoS21 Europe PMC20 |
| 2015 | Sluggett, J., Caughey, G., Ward, M., & Gilbert, A. (2015). Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study. International Journal of Clinical Pharmacy, 37(5), 782-789. Scopus5 WoS3 Europe PMC3 |
| 2015 | Caughey, G., Kalisch Ellett, L., Goldstein, S., & Roughead, E. (2015). Suboptimal medication-related quality of care preceding hospitalisation of older patients. Medical Journal of Australia, 203(5), 220.e1-220.e7. Scopus6 WoS6 Europe PMC6 |
| 2014 | Sluggett, J., Caughey, G., Ward, M., & Gilbert, A. (2014). Antithrombotic use following transient ischaemic attack or ischaemic stroke among older Australians with atrial fibrillation. Internal Medicine Journal, 44(11), 1134-1137. Scopus1 WoS1 Europe PMC1 |
| 2014 | McDonald, C., Kalisch Ellett, L., Barratt, J., & Caughey, G. (2014). A cross-country comparison of rivaroxaban spontaneous adverse event reports and concomitant medicine use with the potential to increase the risk of harm. Drug Safety, 37(12), 1029-1035. Scopus16 WoS15 Europe PMC13 |
| 2014 | Li, L., Caughey, G., & Johnston, K. (2014). Comorbidity associated with referral to pulmonary rehabilitation in people hospitalized with chronic obstructive pulmonary disease. Journal of Cardiopulmonary Rehabilitation and Prevention, 34(6), 430-436. Scopus4 WoS4 Europe PMC4 |
| 2014 | Sluggett, J., Caughey, G., Ward, M., & Gilbert, A. (2014). Use of secondary stroke prevention medicines in Australia: National trends, 2003-2009. Medical Journal of Australia, 201(1), 54-57. Scopus7 WoS6 Europe PMC6 |
| 2014 | Li, L., Caughey, G., & Johnston, K. (2014). The association between co-morbidities and physical performance in people with chronic obstructive pulmonary disease: A systematic review. Chronic Respiratory Disease, 11(1), 3-13. Scopus11 WoS10 Europe PMC7 |
| 2014 | Simpson, B., Luo, X., Costabile, M., Caughey, G., Wang, J., Claudie, D., . . . Semple, S. (2014). Polyandric acid A, a clerodane diterpenoid from the Australian medicinal plant Dodonaea polyandra, attenuates pro-inflammatory cytokine secretion in vitro and in vivo. Journal of Natural Products, 77(1), 85-91. Scopus23 WoS22 Europe PMC12 |
| 2014 | Caughey, G., Kalisch Ellett, L., & Wong, T. (2014). Development of evidence-based Australian medication-related indicators of potentially preventable hospitalisations: a modified RAND appropriateness method. BMJ Open, 4(4), e004625-1-e004625-17. Scopus26 WoS24 Europe PMC19 |
| 2014 | Sluggett, J. K., Caughey, G. E., Ward, M. B., & Gilbert, A. L. (2014). Doubling in use of alteplase in Australia between 2003 and 2009. International Journal of Stroke, 9(6), E28. |
| 2014 | Pratt, N., Graves, S., Cashman, K., Caughey, G., & Roughead, E. (2014). Anti-Coagulation After Hip or Knee Joint Replacement: Assessment of the Benefits and Risks in an Elderly Cohort. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 23, 485-486. |
| 2014 | Pratt, N., Ramsay, E., Kemp, A., Kalisch-Ellett, L., Shakib, S., Caughey, G., . . . Roughead, E. (2014). Ranibizumab and risk of hospitalisation for ischaemic stroke and myocardial infarction in patients with age-related macular degeneration: a self-controlled case-series analysis. Drug Safety, 37(12), 1021-1027. Scopus17 WoS13 Europe PMC14 |
| 2014 | Vitry, A., Nguyen, T., Ramsay, E., Caughey, G., Gilbert, A., Shakib, S., . . . Roughead, E. (2014). General practitioner management plans delaying time to next potentially preventable hospitalisation for patients with heart failure. Internal Medicine Journal, 44(11), 1117-1123. Scopus17 WoS14 Europe PMC17 |
| 2014 | Ho, T., Caughey, G., & Shakib, S. (2014). Guideline compliance in chronic heart failure patients with multiple comorbid diseases: evaluation of an individualised multidisciplinary model of care. PLoS One, 9(4), e93129-1-e93129-7. Scopus20 WoS17 Europe PMC17 |
| 2013 | Caughey, G., Preiss, A., Vitry, A., Gilbert, A., Ryan, P., Shakib, S., . . . Roughead, E. (2013). Does antidepressant medication use affect persistence with diabetes medicines?. Pharmacoepidemiology and Drug Safety, 22(6), 615-622. Scopus16 WoS15 Europe PMC13 |
| 2013 | Caughey, G. E., Preiss, A. K., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2013). Comorbid diabetes and copd: impact of corticosteroid use on diabetes complications. Diabetes Care, 36(10), 3009-3014. Scopus55 WoS51 Europe PMC45 |
| 2013 | Sluggett, J. K., Caughey, G. E., Ward, M. B., Roughead, E. E., & Gilbert, A. L. (2013). Transient ischaemic attack and ischaemic stroke: Constructing episodes of care using hospital claims data. BMC Research Notes, 6(1), 128. Scopus8 Europe PMC7 |
| 2012 | Kalisch, L., Caughey, G., Barratt, J., Ramsay, E., Killer, G., Gilbert, A., & Roughead, E. (2012). Prevalence of preventable medication-related hospitalizations in Australia: An opportunity to reduce harm. International Journal for Quality in Health Care, 24(3), 239-249. Scopus63 WoS53 Europe PMC46 |
| 2012 | Vitry, A., Roughead, E., Ramsay, E., Ryan, P., Caughey, G., Esterman, A., . . . McDermott, R. (2012). Chronic disease management: Does the disease affect likelihood of care planning?. Australian Health Review, 36(4), 419-423. Scopus9 WoS10 Europe PMC7 |
| 2011 | Vitry, A., Roughead, E., Ramsay, E., Preiss, A., Ryan, P., Gilbert, A., . . . McDermott, R. (2011). Major bleeding risk associated with warfarin and co-medications in the elderly population. Pharmacoepidemiology and Drug Safety, 20(10), 1057-1063. Scopus52 WoS45 Europe PMC40 |
| 2011 | Gilbert, A., Caughey, G., Vitry, A., Clark, A., Ryan, P., McDermott, R., . . . Roughead, E. (2011). Ageing well: Improving the management of patients with multiple chronic health problems. Australasian Journal on Ageing, 30(Suppl 2), 32-37. Scopus17 WoS18 Europe PMC15 |
| 2011 | Caughey, G., Roughead, E., Shakib, S., Vitry, A., & Gilbert, A. (2011). Co-morbidity and potential treatment conflicts in elderly heart failure patients: A retrospective, cross-sectional study of administrative claims data. Drugs and Aging, 28(7), 575-581. Scopus36 WoS25 Europe PMC30 |
| 2011 | Zhang, Y., Vitry, A., Caughey, G., Roughead, E., Ryan, P., Gilbert, A., . . . McDermott, R. (2011). The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes. Diabetes Research and Clinical Practice, 91(1), 115-120. Scopus5 WoS4 Europe PMC4 |
| 2011 | Roughead, E. E., Vitry, A. I., Caughey, G. E., & Gilbert, A. L. (2011). Multimorbidity, care complexity and prescribing for the elderly. Aging Health, 7(5), 695-705. Scopus47 |
| 2011 | Kalisch, L. M., Caughey, G. E., Roughead, E. E., & Gilbert, A. L. (2011). The prescribing cascade. Australian Prescriber, 34(6), 162-166. Scopus80 WoS60 |
| 2011 | Caughey, G. E., Roughead, E. E., Pratt, N., Killer, G., & Gilbert, A. L. (2011). Stroke risk and NSAIDs: An australian population-based study. Medical Journal of Australia, 195(9), 525-529. Scopus53 WoS39 Europe PMC30 |
| 2011 | Caughey, G. E., & Roughead, E. E. (2011). Multimorbidity research challenges: where to go from here?. Journal of comorbidity, 1(1), 8-10. Europe PMC18 |
| 2010 | Vitry, A. I., Roughead, E. E., Ramsay, E. N., Preiss, A. K., Caughey, G. E., Gilbert, A. L., & Ryan, P. (2010). Major Bleeding Risk Associated with Warfarin and Co-Medications in the Elderly Population. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 19, S132. |
| 2010 | Caughey, G., Roughead, E., Shakib, S., McDermott, R., Vitry, A., & Gilbert, A. (2010). Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age and Ageing, 39(4), 488-494. Scopus47 WoS41 Europe PMC35 |
| 2010 | Vitry, A., Roughead, E., Preiss, A., Ryan, P., Ramsay, E., Gilbert, A., . . . McDermott, R. (2010). Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study. PLoS One, 5(11), 1-5. Scopus34 WoS32 Europe PMC27 |
| 2010 | Caughey, G., Roughead, E., Pratt, N., Shakib, S., Vitry, A., & Gilbert, A. (2010). Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?. Pharmacoepidemiology and Drug Safety, 19(9), 977-982. Scopus62 WoS57 Europe PMC45 |
| 2010 | Caughey, G., James, M., Proudman, S., & Cleland, L. (2010). Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumatoid arthritis patients. Complementary Therapies in Medicine, 18(3-4), 171-174. Scopus36 WoS32 Europe PMC20 |
| 2010 | Zhang, Y., Chow, V., Vitry, A., Ryan, P., Roughead, E., Caughey, G., . . . Luszcz, M. (2010). Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing. International Psychogeriatrics, 22(3), 437-444. Scopus22 WoS22 Europe PMC21 |
| 2010 | Caughey, G., Roughead, E., Vitry, A., McDermott, R., Shakib, S., & Gilbert, A. (2010). Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Research and Clinical Practice, 87(3), 385-393. Scopus161 WoS144 Europe PMC128 |
| 2010 | Caughey, G., Ramsay, E., Vitry, A., Gilbert, A., Luszcz, M., Ryan, P., & Roughead, E. (2010). Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. Journal of Epidemiology and Community Health, 64(12), 1036-1042. Scopus77 WoS66 Europe PMC69 |
| 2008 | Caughey, G. E., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2008). Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health, 8(1), 13 pages. Scopus180 WoS155 Europe PMC133 |
| 2007 | St-Onge, M., Flamand, N., Biarc, J., Picard, S., Bouchard, L., Dussault, A. A., . . . Pouliot, M. (2007). Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils. Biochimica Et Biophysica Acta Molecular and Cell Biology of Lipids, 1771(9), 1235-1245. Scopus54 WoS53 Europe PMC46 |
| 2007 | Proudman, S., Keen, H., Stamp, L., Lee, A., Goldblatt, F., Ayres, O., . . . Cleland, L. (2007). Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Seminars in Arthritis and Rheumatism, 37(2), 99-111. Scopus64 WoS65 Europe PMC54 |
| 2006 | Cleland, L., Caughey, G., James, M., & Proudman, S. (2006). Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. Journal of Rheumatology, 33(10), 1973-1979. Scopus103 WoS88 Europe PMC50 |
| 2005 | Cleland, L., James, M., Keen, H., Danda, D., Caughey, G., & Proudman, S. (2005). Fish oil - an example of an anti-inflammatory food. Asia Pacific Journal of Clinical Nutrition, 14(SUPPL.), 66-71. Scopus10 |
| 2003 | Demasi, M., Cleland, L., Cook-Johnson, R., Caughey, G., & James, M. (2003). Effects of hypoxia on monocyte inflammatory mediator production - Dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis. Journal of Biological Chemistry, 278(40), 38607-38616. Scopus40 WoS41 Europe PMC30 |
| 2003 | Demasi, M., Cleland, L. G., Cook-Johnson, R. J., Caughey, G. E., & James, M. J. (2003). Retraction: Effects of hypoxia on monocyte inflammatory mediator production: Dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis (Journal of Biological Chemistry (2003) 278 (38607–38616) DOI: 10.1074/jbc.A117.305944). Journal of Biological Chemistry, 293(52), 20013. |
| 2001 | Schmidlin, F., Amadesi, S., Vidil, R., Trevisani, M., Martinet, N., Caughey, G., . . . Bunnett, N. W. (2001). Expression and function of proteinase-activated receptor 2 in human bronchial smooth muscle. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 164(7), 1276-1281. WoS82 Europe PMC71 |
| 2001 | James, M., Penglis, P., Caughey, G., Demasi, M., & Cleland, L. (2001). Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?. Inflammation Research, 50(5), 249-253. Scopus33 WoS34 Europe PMC26 |
| 2001 | Caughey, G., Cleland, L., Penglis, P., Gamble, J., & James, M. (2001). Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: Selective up-regulation of prostacyclin synthesis by COX-2. Journal of Immunology, 167(5), 2831-2838. Scopus268 WoS239 Europe PMC195 |
| 2001 | Caughey, G., Cleland, L., Gamble, J., & James, M. (2001). Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets - Role of thromboxane A(2). Journal of Biological Chemistry, 276(41), 37839-37845. Scopus83 WoS75 Europe PMC54 |
| 2000 | Penglis, P., Cleland, L., Demasi, M., Caughey, G., & James, M. (2000). Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: Implications for the use of cyclooxygenase inhibitors. Journal of Immunology, 165(3), 1605-1611. Scopus96 WoS89 Europe PMC72 |
| 2000 | Demasi, M., Caughey, G., James, M., & Cleland, L. (2000). Assay of cyclooxygenase-1 and 2 in human monocytes. Inflammation Research, 49(12), 737-743. Scopus37 WoS37 Europe PMC26 |
| 1997 | Caughey, G., Pouliot, M., Cleland, L., & James, M. (1997). Regulation of tumor necrosis factor-a and interleukin-1b synthesis by thromboxane A2 in nonadherent human monocytes.. Journal of Immunology, 158(1), 351-358. Scopus115 WoS103 Europe PMC49 |
| 1996 | Caughey, G. E., Mantzioris, E., Gibson, R. A., Cleland, L. G., & James, M. J. (1996). The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. American Journal of Clinical Nutrition, 63(1), 116-122. Scopus753 WoS645 Europe PMC500 |
| Year | Citation |
|---|---|
| 2012 | Caughey, G. E., James, M. J., & Cleland, L. G. (2012). Prostaglandins and Leukotrienes. In Encyclopedia of Human Nutrition (Vol. 4-4, pp. 104-110). Elsevier. DOI |
| 2005 | Caughey, G. E., James, M. J., & Cleland, L. G. (2005). Prostaglandins and leukotrienes. In B. Caballero (Ed.), Encyclopedia of Human Nutrition (pp. 42-49). Elsevier. DOI Scopus3 |
| Year | Citation |
|---|---|
| 2020 | Chen, T. -C., Wettermark, B., Steinke, D., Caughey, G., Tadrous, M., Wirtz, V., & Chen, L. -C. (2020). Comparing opioid regulations globally across regions with different levels of opioid utilisation. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 29 (pp. 165). WILEY. |
| 2020 | Caughey, G. E., Lang, C., Sluggett, J., Wesselingh, S., & Inacio, M. C. (2020). Influence of Dementia on Medication-related Quality of Care in Long-term Aged Care. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 29 (pp. 215). WILEY. |
| 2020 | Chen, T. -C., Wettermark, B., Steinke, D., Caughey, G., Tadrous, M., Wirtz, V., & Chen, L. -C. (2020). Assessing the feasibility of leveraging healthcare databases to conduct cross-national comparisons of opioid utilisation. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 29 (pp. 187-188). WILEY. |
| 2018 | Yuson, C., Caughey, G., Shakib, S., & Smith, W. (2018). POPULATION PREVALENCE OF DRUG ALLERGY IN SOUTH AUSTRALIA. In INTERNAL MEDICINE JOURNAL Vol. 48 (pp. 16). WILEY. WoS1 |
| 2017 | Molga, A., Wall, M., Singhal, D., Chhetri, R., Wee, A., Cussans, L., . . . Hiwase, D. K. (2017). A Geriatric Screening Tool (G8) Provides an Independent Prognostic Index for Azacitidine Treated Elderly MDS Patients. In BLOOD Vol. 130 (pp. 3 pages). GA, Atlanta: AMER SOC HEMATOLOGY. |
| 2013 | Caughey, G. E., & Kalisch, L. M. (2013). Development of Evidence Based Medication Related Indicators of Potentially Preventable Hospitalisations. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 22 (pp. 458-459). WILEY-BLACKWELL. |
| 2012 | Gilbert, A., Roughead, E., Avorn, J., Andersen, M., & Caughey, G. (2012). Pharmacoepidemiology: The Essential Discipline in the Provision of Safe and Effective Care for Older Patients with Multimorbidity. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 193-194). WILEY PERIODICALS, INC. |
| 2012 | Caughey, G. E., Preiss, A. K., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2012). Antidepressants and Risk of Discontinuation of Diabetes Medicines. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 188). WILEY PERIODICALS, INC. |
| 2012 | Vitry, A. I., Eeow, Z. H., & Caughey, G. E. (2012). International Comparison of the Utilisation of Anti-Diabetic Medicines. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 163-164). WILEY PERIODICALS, INC. |
| 2012 | Sluggett, J. K., Caughey, G. E., Ward, M. B., & Gilbert, A. L. (2012). Drug Treatment after Transient ischaemic Attack or Ischaemic Stroke: Are We Doing Enough to Reduce Secondary Risk?. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 29). WILEY PERIODICALS, INC. |
| 2011 | Caughey, G. E., Preiss, A. K., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2011). Increased Risk of Hospitalisation with Corticosteroid Use in Patients with Diabetes and COPD. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 20 (pp. S284). WILEY-BLACKWELL. |
| 2010 | Caughey, G., Roughead, E., Pratt, N., Shakib, S., Vitry, A., & Gilbert, A. (2010). Adverse Outcomes Associated with Potential Prescribing Cascades. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 19 (pp. S130-S131). Brighton, ENGLAND: WILEY-BLACKWELL. |
| 2009 | Caughey, G., Vitry, A., Gilbert, A., & Roughead, E. (2009). Polypharmacy in Chronic Diseases in the Elderly: Evidence-Based or Potentially Inappropriate Prescribing?. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 18 (pp. S197-S198). JOHN WILEY & SONS LTD. |
| 2009 | Vitry, A., Roughead, E., Ramsay, E., Preiss, K., Ryan, P., Esterman, A., . . . Caughey, G. (2009). Risk in older patients of major bleeding associated with warfarin when other medicines are co-prescribed for concomitant medical conditions. In AUSTRALASIAN JOURNAL ON AGEING Vol. 28 (pp. A119). WILEY-BLACKWELL PUBLISHING, INC. |
| 2008 | Zhang, Y., Vitry, A., Chow, V., & Caughey, G. E. (2008). Antidepressant use among the Australian elderly: A longitudinal study. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 17 (pp. S91-S92). WILEY-BLACKWELL. |
| 2007 | Cleland, L. G., Caughey, G. E., Proudman, S. M., James, M. J., & Lee, A. T. Y. (2007). Fish oil treatment and cardiovascular risk in early rheumatoid arthritis. In ANNALS OF THE RHEUMATIC DISEASES Vol. 66 (pp. 347). Barcelona, SPAIN: B M J PUBLISHING GROUP. WoS1 |
| 2007 | Cottrell, G. S., Amadesi, S., Pikios, S., Camerer, E., Willardsen, A., Murphy, B., . . . Grady, E. E. (2007). Protease-activated receptor 2, dipeptidyl peptidase I and tryptic proteases mediate <i>Clostridium difficile</i> toxin a-induced ileitis in mice. In GASTROENTEROLOGY Vol. 132 (pp. A388). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. WoS2 |
| 2000 | Cleland, L. G., Penglis, P. S., Caughey, G. E., & James, M. J. (2000). Increased TXA<sub>2</sub>/PGE<sub>2</sub> ratio with COX-2 inhibition;: Modulation of TNFα production in human monocytes.. In ARTHRITIS AND RHEUMATISM Vol. 43 (pp. S80). LIPPINCOTT WILLIAMS & WILKINS. |
| Year | Citation |
|---|---|
| 2023 | Sluggett, J. K., Air, T., Inacio, M. C., Lang, C., Ward, S. A., Ahern, S., . . . Caughey, G. E. (2023). National surveillance using a clinical quality indicator for prolonged antipsychotic use among older Australians living with dementia who access aged care services. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY. DOI |
| 2022 | Dyer, S., Suen, J., Inacio, M., & Caughey, G. (2022). Impact of relational continuity of primary care in aged care: A systematic review. Poster session presented at the meeting of AUSTRALASIAN JOURNAL ON AGEING. WILEY. |
| 2020 | Inacio, M. C., Lang, C., Caughey, G., Bray, S., Whitehead, C., Visvanathan, R., . . . Wesselingh, S. (2020). Quality and Safety Indicators for Long-term Care in Australia. Poster session presented at the meeting of JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. Long Beach, CA: WILEY. |
| 2019 | Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. (2019). HOW DO CLINICIANS AND PHARMACISTS ASSESS POLYPHARMACY IN A CASE-BASED SETTING?. Poster session presented at the meeting of RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY. ELSEVIER SCIENCE INC. |
| 2019 | Molga, A., Wall, M., Hiwase, D., Chhetri, R., Wee, A., Caughey, G., & Shakib, S. (2019). Geriatric assessment in older people with Myelodysplasia is predictive of Azacitidine therapy completion and survival: a multidisciplinary translational research initiative at the Royal Adelaide Hospital. Poster session presented at the meeting of AUSTRALASIAN JOURNAL ON AGEING. WILEY. |
| 2019 | Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. (2019). Identifying patients at risk of adverse outcomes from inappropriate polypharmacy. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY. |
| 2018 | Molga, A., Wall, M., Chhetri, R., Wee, A., Singhal, D., Singhal, N., . . . Hiwase, D. K. (2018). Geriatric Assessment in Older People with Myelodysplasia Is Predictive of Azacitidine Therapy Completion and Survival: A Prospective Interventional Study at the Royal Adelaide Hospital. Poster session presented at the meeting of BLOOD. CA, San Diego: AMER SOC HEMATOLOGY. DOI WoS2 |
| 2017 | Caughey, G. E., Huynh, E., Shakib, S., Rose, J. M., & Swait, J. (2017). Influence of Medication Risks and Benefits on Patient and Clinician Preferences for Treatment in Multimorbidity: A Discrete-Choice Experiment. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY. WoS1 |
| 2017 | Caughey, G. E., Gadzhanova, S., Shakib, S., & Roughead, E. E. (2017). Trends in Concomitant Prescribing of Opioids and Benzodiazepines in Australia 2010-2015; a Cause for Concern?. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY. |
| 2017 | Caughey, G. E., Taxis, K., Pont, L. G., Zongo, A., & Wettermark, B. (2017). Evidence Generation in Multimorbidity: A New Frontier in Drug Utilization. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY. |
| 2017 | Ramsay, E., Pratt, N., Ellett, L. K., Shakib, S., Caughey, G., Kemp-Casey, A., & Roughead, E. (2017). Post-Market Surveillance of Aflibercept for Macular Degeneration. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY. |
| 2017 | Gabb, G. M., Caughey, G., Ronson, S., Ward, M., Hill, C. L., & Limaye, V. (2017). ASSOCIATION OF IDIOPATHIC INFLAMMATORY MYOSITIS WITH STATIN EXPOSURE: A POPULATION BASED CASE CONTROL AND ECOLOGICAL STUDY. Poster session presented at the meeting of HYPERTENSION. Hobart, AUSTRALIA: LIPPINCOTT WILLIAMS & WILKINS. WoS1 |
| 2016 | Foreman, C., Thanh-Thao, L., Caughey, G., Shakib, S., & Smith, W. (2016). DRUG ALLERGY REPORTS ON MEDICALERT® DEVICES. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. DOI |
| 2016 | Caughey, G. E., Gabb, G. M., Ronson, S., Ward, M., Hill, C. L., & Limaye, V. (2016). Association of Idiopathic Inflammatory Myositis with Statin Exposure: A Population Based Case Control Study. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL. |
| 2016 | Caughey, G. E., Barratt, J. D., Shakib, S., Kemp-Casey, A., & Roughead, E. E. (2016). Medication Use and Potentially High Risk Prescribing in Older Patients Hospitalised for Diabetes: A Missed Opportunity to Improve Care?. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL. |
| 2015 | Caughey, G. E., Ellett, L. M. K., & Barratt, J. D. (2015). Spontaneous adverse event reports associated with apixaban and potentially inappropriate medicine use: an international comparison. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL. |
| 2015 | Caughey, G., Taxis, K., Wettermark, B., Sketris, I., Chen, L. -C., & Pont, L. (2015). An International Working Collaborative to Examine Global Drug Utilisation: Opioid Use and Misuse. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL. WoS1 |
| 2014 | Sluggett, J. K., Caughey, G. E., Ward, M. B., & Gilbert, A. L. (2014). National changes in transient ischemic attack and ischemic stroke care: Increased uptake of guideline-recommended medicines between 2003 and 2009. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF STROKE. WILEY-BLACKWELL. |
| 2014 | Caughey, G. E., & Ellett, L. M. K. (2014). Prevalence of Suboptimal Processes of Care Prior to Hospitalisation. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL. |
| 2014 | Gregoire, J. -P., Denig, P., Dormuth, C., & Caughey, G. (2014). Adherence to Drug Treatment: A Practical Look at Complex Measurement Issues. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL. |
| 2014 | Ellet, L. M. K., McDonald, C. J., Barratt, J. D., & Caughey, G. E. (2014). An International Comparison of Spontaneous Adverse Event Reports and Potentially Inappropriate Medicine Use Associated with Dabigatran. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL. |
| 2014 | Sluggett, J. K., Caughey, G. E., Ward, M. B., & Gilbert, A. L. (2014). Health Outcomes for Older Australians After Transient Ischaemic Attack (TIA) or Ischaemic Stroke (IS). Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL. |
| 2014 | Johnston, J., Li, L., & Caughey, G. (2014). COMORBIDITY IS ASSOCIATED WITH REFERRAL TO PULMONARY REHABILITATION IN PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Poster session presented at the meeting of RESPIROLOGY. WILEY-BLACKWELL. |
| 2014 | Pratt, N., Ramsay, E., Kemp, A., Ellett, L. K., Shakib, S., Caughey, G., . . . Roughead, E. (2014). Ranibizumab Associated with Increased Risk of Ischaemic Stroke but Not Myocardial Infarct: A Self-Controlled Case Series Analysis. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL. |
| 2012 | Caughey, G. E., Vitry, A. I., Gilbert, A., Pratt, N., Shakib, S., & Roughead, E. E. (2012). Medication issues and strategies to improve health outcomes for older patients with heart failure. Poster session presented at the meeting of AUSTRALASIAN JOURNAL ON AGEING. WILEY-BLACKWELL. |
| 1995 | James, M., Mantzioris, E., Caughey, G., Cleland, L., & Gibson, R. (1995). Effect of dietary N-3 fatty-acids on human monocyte (MC) tumor-necrosis-factor-alpha (TNF-alpha) and interleukin-1-beta (IL-1-beta) synthesis. Poster session presented at the meeting of Abstracts of Experimental Biology '95, as published in The FASEB Journal. Atlanta, Georgia: Federation of American Society of Experimental Biology. |
| Year | Citation |
|---|---|
| 2021 | Masnoon, N., Shakib, S., Ellett, L. K., & Caughey, G. (2021). What Medication-Related Factors Are Important For Polypharmacy And Deprescribing Assessment By Physicians And Pharmacists Using A Novel Website To Rate Clinical Cases?. DOI |
| 2021 | Dyer, S., Suen, J., Williams, H., Inacio, M., Harvey, G., Roder, D., . . . Caughey, G. (2021). Impact of Relational Continuity of Primary Care in Aged Care: A Systematic Review. DOI |
| 2019 | Davis, K. M., Eckert, M. C., Shakib, S., Harmon, J., Hutchinson, A. D., Sharplin, G., & Caughey, G. E. (2019). Development and Implementation of a Nurse-Led Model of Care Coordination to Provide Health-Sector Continuity of Care for People With Multimorbidity: Protocol for a Mixed Methods Study (Preprint). DOI |
- 2018-2020 Team Approach to Polypharmacy Evaluation and Reduction for General Practice patients with dementia: the Australian TAPERdem study. NHMRC, Boosting Dementia Research Grants. C Etherton-Beer, L Parkinson, V, Naganathan, GE Caughey, J Redfern, R Clifford, A Page, D Mangin, $586,840.40
- 2012-2017 Centre of Excellence in post-marketing surveillance of medicines and devices, NHMRC Centre of Excellence, E Roughead, P Ryan, S Graves, N Pratt, S Shakib, GE Caughey, N Huang $2,501,247
- 2015-2016 Understanding patient preferences and treatment priorities in those with multiple chronic conditions: an opportunity to improve health outcomes. UniSA Research Investment Themes. GE Caughey, J Swait, J Rose, E Huynh $37,857
- 2016 Implementation of Clinical Indicators of potentially preventable hospitalisation. GE Caughey, L Kalisch Ellett, S Bacon, N Bullock SA Government Innovation Program $33,350
- 2012 Examination of barriers and facilitators to achieving quality use of medicines along the continuum of care. SA Health GE Caughey, Simon Bell, Manya Angley, Kay Price, Michael Ward $45,000
- 2011-2013 Development of Australian clinical indicators for potentially preventable hospitalisations BUPA Foundation GE Caughey, L Kalisch $200,409
- 2011-2013 Development and evaluation of new anti-inflammatory products based on a traditional Indigenous medicine NHMRC Development Grant $269,590 S Semple, R McKinnon, J Wang, GE Caughey, M Constabile
- 2007-2011 The development and evaluation of management strategies designed to address poly-morbidity in older people: Implications for health policy planning, practitioners and patients. 2007 – 2010. NHMRC Ageing Well Ageing Productively Grant. AL Gilbert, EE Roughead, R McDermott, A Esterman, M Luszcz, S Shakib. AI GE Caughey $2,000,000.
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2022 | Co-Supervisor | Optimising medication use and improving health outcomes in older adults with multimorbidity | Doctor of Philosophy | Doctorate | Part Time | Dr Joshua Mark Inglis |
| 2019 | Co-Supervisor | Frailty in Patients with Haematological Malignancies | Doctor of Philosophy | Doctorate | Part Time | Dr Angela Teresa Molga |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2017 - ongoing | Chair | Chair, Educational Program, Drug Utilisation Special Interest Group | International Society for Pharmacoepidemiology | United States |
| 2016 - ongoing | Co-Founder | Asian Drug Utilisation Special Interest Group | International Society for Pharmacoepidemiology | Australia |
| 2016 - ongoing | Co-Founder | Medicines and Ageing Research Collaborative (MARC) | Royal Adelaide Hospital | Australia |
| 2014 - ongoing | Member | Multimorbidity Executive Working Group | Royal Australian College of General Practice | Australia |
| 2011 - ongoing | Board Member | Drug Utilisation Special Interest Group Executive Committee | International Society for Pharmacoepidemiology | United States |
| 2009 - 2015 | Member | Scientific Program Committee | International Society for Pharmacoepidemiology | United States |
| 2009 - ongoing | Member | International Research Community on Multimorbidity | Multimorbidity Research Community | Canada |
| 2009 - ongoing | Member | Medicines Use Research Australia | International Society for Pharmacoepidemiology | Australia |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2010 - ongoing | Board Member | Journal of Comorbidity | SAGE Journals | United Kingdom |
Connect With Me
External Profiles
